查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714251

大分子生物分析技術市場－全球產業規模、佔有率、趨勢、機會和預測，按產品和服務（產品、服務）、應用、地區和競爭細分，2020-2030 年

Large Molecule Bioanalytical Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Product, Service), By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球大分子生物分析技術市場價值為 95.4 億美元，預計到 2030 年將達到 172.1 億美元，預測期內複合年成長率將達到 10.31%。生物製劑和生物相似藥管道的不斷擴大，以及在治療慢性和危及生命的疾病方面對生物療法而非小分子療法的日益青睞，推動了市場的成長。這些先進的治療方法需要精確的分析工具，以便在藥物開發的所有階段進行準確的表徵、量化和驗證。單株抗體、重組蛋白和基因療法的使用增加促使製藥公司和研究機構投資高通量、敏感技術。混合分析平台、數位自動化和人工智慧整合等新興趨勢正在進一步改變生物分析工作流程。儘管該行業受益於技術進步，但它仍然面臨著高資本投入和嚴格監管標準相關的挑戰。生物製劑的複雜性也要求分析方法不斷創新和標準化，從而強化先進生物分析技術在生物製藥產業的關鍵角色。

市場概覽
預測期 2026-2030
2024年市場規模 95.4億美元
2030年市場規模 172.1億美元
2025-2030 年複合年成長率 10.31%
成長最快的領域 細胞與基因治療
最大的市場 北美洲

關鍵市場促進因素

對生物製劑和生物相似藥的需求不斷成長

主要市場挑戰

先進分析儀器成本高昂

主要市場趨勢

採用混合分析技術

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球大分子生物分析技術市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品及服務（產品（耗材及配件、儀器、試劑及試劑盒）、服務）
    • 依應用（生物製劑、寡核苷酸衍生藥物和分子、病毒載體、細胞和基因治療、奈米顆粒和聚合物、其他）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美大分子生物分析技術市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲大分子生物分析技術市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太大分子生物分析技術市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美大分子生物分析技術市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲大分子生物分析技術市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis BV

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 28302

The global market for large molecule bioanalytical technologies was valued at USD 9.54 billion in 2024 and is projected to reach USD 17.21 billion by 2030, registering a robust CAGR of 10.31% during the forecast period. Market growth is being fueled by the expanding pipeline of biologics and biosimilars, along with the increasing preference for biologic therapies over small molecules in treating chronic and life-threatening conditions. These advanced therapeutics require precise analytical tools for accurate characterization, quantification, and validation across all phases of drug development. The rise in the use of monoclonal antibodies, recombinant proteins, and gene therapies is prompting pharmaceutical companies and research organizations to invest in high-throughput, sensitive technologies. Emerging trends such as hybrid analytical platforms, digital automation, and AI integration are further transforming bioanalytical workflows. While the sector benefits from technological progress, it continues to face challenges related to high capital investment and stringent regulatory standards. The complexity of biologics also necessitates ongoing innovation and standardization in analytical methodologies, reinforcing the critical role of advanced bioanalytical technologies in the biopharmaceutical industry.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 9.54 Billion
Market Size 2030USD 17.21 Billion
CAGR 2025-203010.31%
Fastest Growing SegmentCell & Gene Therapy
Largest MarketNorth America

Key Market Drivers

Growing Demand for Biologics and Biosimilars

The global shift toward biologics and biosimilars as preferred therapeutic modalities is a key driver of demand for large molecule bioanalytical technologies. Biologics, including monoclonal antibodies and therapeutic proteins, offer high specificity and efficacy in treating complex conditions such as cancer and autoimmune diseases. As these therapies require extensive analytical testing throughout their development and regulatory lifecycle, the need for reliable, high-precision bioanalytical platforms has grown significantly. Additionally, regulatory mandates for biosimilar comparability studies further intensify the demand for advanced analytical solutions to evaluate safety, efficacy, and quality. The increasing adoption of biologics across diverse therapeutic areas ensures a sustained need for robust, sensitive, and scalable bioanalytical technologies.

Key Market Challenges

High Costs of Advanced Analytical Instruments

The adoption of large molecule bioanalytical technologies is often hindered by the high costs associated with procuring and operating advanced instruments. Technologies such as LC-MS/MS and surface plasmon resonance systems require substantial capital investment and ongoing operational expenses. These costs include maintenance, calibration, consumables, and software licensing. For small and mid-sized laboratories or emerging biotech firms, such financial demands can be a major constraint. This challenge is compounded by the need for highly skilled personnel to operate and maintain these systems, limiting market penetration in resource-constrained settings.

Key Market Trends

Adoption of Hybrid Analytical Techniques

An emerging trend in the market is the increased use of hybrid analytical methods, particularly those that integrate ligand-binding assays with LC-MS/MS. This combination enhances both sensitivity and specificity, making it ideal for analyzing complex biologics such as monoclonal antibodies and fusion proteins. These techniques are especially useful in pharmacokinetics, pharmacodynamics, and immunogenicity studies, where the detection of trace levels of analytes in complex biological samples is critical. Regulatory bodies are acknowledging the value of these integrated approaches, further promoting their adoption in both early-stage research and clinical development.

Key Market Players

  • Intertek Group plc
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Verder Scientific GmbH & Co. KG
  • Charles River Laboratories
  • Merck KGaA
  • Cergentis B.V.

Report Scope:

In this report, the Global Large Molecule Bioanalytical Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Large Molecule Bioanalytical Technologies Market, By Products & Services:

  • Product

Consumables & Accessories

Instruments

Reagents & Kits

  • Service

Large Molecule Bioanalytical Technologies Market, By Application:

  • Biologics
  • Oligonucleotide Derived Drugs & Molecules
  • Viral Vector
  • Cell & Gene Therapy
  • Nanoparticles & Polymers
  • Others

Large Molecule Bioanalytical Technologies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Large Molecule Bioanalytical Technologies Market.

Available Customizations:

Global Large Molecule Bioanalytical Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Large Molecule Bioanalytical Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Product (Consumables & Accessories, Instruments, Reagents & Kits), Service)
    • 5.2.2. By Application (Biologics, Oligonucleotide Derived Drugs & Molecules, Viral Vector, Cell & Gene Therapy, Nanoparticles & Polymers, Others)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Large Molecule Bioanalytical Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Large Molecule Bioanalytical Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application

7. Europe Large Molecule Bioanalytical Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Large Molecule Bioanalytical Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application

8. Asia-Pacific Large Molecule Bioanalytical Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
    • 8.3.2. India Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Large Molecule Bioanalytical Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application

9. South America Large Molecule Bioanalytical Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Large Molecule Bioanalytical Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application

10. Middle East and Africa Large Molecule Bioanalytical Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Large Molecule Bioanalytical Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Intertek Group plc
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd
  • 14.3. Bio-Rad Laboratories, Inc.
  • 14.4. Solvias
  • 14.5. Bio-Techne
  • 14.6. Waters Corporation
  • 14.7. Verder Scientific GmbH & Co. KG
  • 14.8. Charles River Laboratories
  • 14.9. Merck KGaA
  • 14.10. Cergentis B.V.

15. Strategic Recommendations

16. About Us & Disclaimer